FIELD: chemistry.
SUBSTANCE: formula compound is described, where X is oxygen; R1 is a linear or branched C1-C8-alkyl chain, substituted with phenyl, optionally substituted with halogen atoms; R2, R3 independently represent hydrogen, C1-C3-alkyl chain, halogen, methoxy; R4, R5, R6, R7 independently represent hydrogen, as well as a method of obtaining formula (I) compound, and a pharmaceutical composition.
EFFECT: use of the compound to make a medicinal agent which is effective as a modulator of the sodium and/or calcium channel and, consequently, suitable for preventing, relieving and treating a wide range of pathologies which include neurological, psychiatric, cardiovascular, phlogistic, eye, urological, metabolic and intestinal diseases, where the above mentioned mechanisms are described as playing a pathological role.
6 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF USAGE OF (HALO BENZYLOXY)BENZYLAMINO-PROPANAMIDE FOR PRODUCTION OF MEDICATIONS WITH SELECTIVE MODULATING ACTIVITY ON SODIUM AND/OR CALCIUM CHANNELS | 2005 |
|
RU2391973C2 |
N-ACYL-N' -BENZYLALYLENEDIAMNO DERIVATIVES | 2004 |
|
RU2387636C2 |
2-PHENYLETHYLAMINO DERIVATIVES AS CALCIUM AND/OR SODIUM CHANNEL MODULATORS | 2006 |
|
RU2397160C9 |
3-AMINOPYRROLIDONE DERIVATIVES | 2004 |
|
RU2395495C2 |
SUBSTITUTED TRIAZOLES AS SODIUM CHANNEL BLOCKERS | 2004 |
|
RU2372339C2 |
ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS | 2007 |
|
RU2470012C2 |
PYRIDINEAMIDE DERIVATIVES AND MEDICINAL AGENT BASED ON THEREOF | 2003 |
|
RU2309950C2 |
PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR LOCAL ADMINISTRATION AND USE THEREOF AS THERAPEUTIC AGENTS | 2011 |
|
RU2596488C2 |
DERIVATIVES OF CINNAMIC ACID AMIDE | 2003 |
|
RU2318802C2 |
Authors
Dates
2009-11-10—Published
2004-11-12—Filed